entertainment -WSS

entertainment

author：comprehensive 2025-10-02 18:05:17 - browse：23

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

WSS

Belarusian journalist sentenced to 4 years in prison as crackdown continues

ARCH Venture Partners is raising $3 billion for a life sciences fund

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Commercial surrogacy can be ethical, despite pope’s claims

Supreme Court strikes down Biden student loan forgiveness program

Congressmen charge Covid hearing ‘could have been an email’

hotspot

entertainment

leisure time

How to save PrEP access — and even expand it

New Ultima Genomics DNA sequencer can read genome for $100

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ARCH Venture Partners is raising $3 billion for a life sciences fund

After affirmative action ruling, medical educators look to 'holistic review'

The simple reason for the increase in autism diagnosis

New air purifier tech could be key to improving indoor air quality

Congressmen charge Covid hearing ‘could have been an email’

Alkermes shareholders re

Commercial surrogacy can be ethical, despite pope’s claims

Wikipedia

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Biden administration opens offers in Medicare drug price negotiations

Novo Nordisk to expand supply of Wegovy for U.S. patients

Cybersecurity threat forces Lurie Children's to take systems offline

Novo Nordisk to expand supply of Wegovy for U.S. patients

Commercial surrogacy can be ethical, despite pope’s claims

hotspot

focus

entertainment

hotspot